Literature DB >> 9925662

The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds.

C R Pullinger1, D Gaffney, M M Gutierrez, M J Malloy, V N Schumaker, C J Packard, J P Kane.   

Abstract

Familial ligand-defective apolipoprotein B (apoB) is a group of disorders caused by mutations in the apoB gene. In this report the R3531C mutation is characterized further using a monoclonal antibody MB19/dynamic laser light scattering technique to measure ratios of Cys(3531) to normal low density lipoprotein (LDL) particles. All six subjects studied showed a preferential accumulation of particles carrying the defective apoB allotype. We determined binding properties of LDL from R3531C heterozygotes by measurement of high-affinity binding to LDL receptors on fibroblasts and its ability promote growth of U937 cells. LDL from R3531C heterozygotes, compared to normal LDL, had 49.3% of the binding affinity and was 74% as effective in a U937 cell proliferation assay. To identify new probands, we screened 2570 subjects for the R3531C mutation. Nine probands were found with 15 affected relatives. Of the seven haplotypes we uncovered, two were novel, while five were identical to one initially reported as associated with Cys3531. Three silent mutations were detected also: T3540T, N3542N and T3552T. Analysis of lipid profiles of R3531C families showed, as with the R3500Q mutation, variable expression of the phenotype, modulated by environmental and other genetic factors. Both mutations tend to produce lower plasma levels of LDL in affected subjects than do defects of the LDL receptor (familial hypercholesterolemia, FH). This study shows that the Cys(3531) LDL particles are not only defective at binding to the LDL receptor, as determined by two separate methods, but that in all cases they accumulate preferentially compared to the normal allotype.-Pullinger, C. R., D. Gaffney, M. M. Gutierrez, M. J. Malloy, V. N. Schumaker, C. J. Packard, and J. P. Kane. Apolipoprotein B R3531C mutation: characteristics of 24 subjects from 9 kindreds. .

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925662

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Three-dimensional structure of low density lipoproteins by electron cryomicroscopy.

Authors:  E V Orlova; M B Sherman; W Chiu; H Mowri; L C Smith; A M Gotto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.

Authors:  R Thiart; C L Scholtz; J Vergotine; C F Hoogendijk; J N de Villiers; H Nissen; K Brusgaard; D Gaffney; M S Hoffs; W J Vermaak; M J Kotze
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

Review 3.  Susceptibility mutations for ischemic heart disease.

Authors:  B G Nordestgaard; A Tybjaerg-Hansen
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

Review 4.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

5.  Genetic variation and atherosclerosis.

Authors:  Erik Biros; Mirko Karan; Jonathan Golledge
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

6.  Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.

Authors:  Clive R Pullinger; Celeste Eng; Gerald Salen; Sarah Shefer; Ashok K Batta; Sandra K Erickson; Andrea Verhagen; Christopher R Rivera; Sean J Mulvihill; Mary J Malloy; John P Kane
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.

Authors:  René Wintjens; Dominique Bozon; Khaldia Belabbas; Félicien MBou; Jean-Philippe Girardet; Patrick Tounian; Mathilde Jolly; Franck Boccara; Ariel Cohen; Alexandra Karsenty; Béatrice Dubern; Jean-Claude Carel; Ahlam Azar-Kolakez; François Feillet; François Labarthe; Anne-Marie Colin Gorsky; Alice Horovitz; Catherine Tamarindi; Pierre Kieffer; Anne Lienhardt; Olivier Lascols; Mathilde Di Filippo; Fabienne Dufernez
Journal:  J Lipid Res       Date:  2016-01-22       Impact factor: 5.922

8.  Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.

Authors:  J A Fernández-Higuero; A Etxebarria; A Benito-Vicente; A C Alves; J L R Arrondo; H Ostolaza; M Bourbon; C Martin
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.